Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP240801.RA52_c26DqfGGXrRaML8xBAr_UzW-FVElm15xsuxWNLf8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP240801.RA52_c26DqfGGXrRaML8xBAr_UzW-FVElm15xsuxWNLf8130_assertion type Assertion NP240801.RA52_c26DqfGGXrRaML8xBAr_UzW-FVElm15xsuxWNLf8130_head.
- NP240801.RA52_c26DqfGGXrRaML8xBAr_UzW-FVElm15xsuxWNLf8130_assertion wasGeneratedBy ECO_0000203 NP240801.RA52_c26DqfGGXrRaML8xBAr_UzW-FVElm15xsuxWNLf8130_provenance.
- NP240801.RA52_c26DqfGGXrRaML8xBAr_UzW-FVElm15xsuxWNLf8130_assertion wasDerivedFrom befree-20140225 NP240801.RA52_c26DqfGGXrRaML8xBAr_UzW-FVElm15xsuxWNLf8130_provenance.
- NP240801.RA52_c26DqfGGXrRaML8xBAr_UzW-FVElm15xsuxWNLf8130_assertion SIO_000772 19062176 NP240801.RA52_c26DqfGGXrRaML8xBAr_UzW-FVElm15xsuxWNLf8130_provenance.
- NP240801.RA52_c26DqfGGXrRaML8xBAr_UzW-FVElm15xsuxWNLf8130_assertion evidence source_evidence_literature NP240801.RA52_c26DqfGGXrRaML8xBAr_UzW-FVElm15xsuxWNLf8130_provenance.
- NP240801.RA52_c26DqfGGXrRaML8xBAr_UzW-FVElm15xsuxWNLf8130_assertion description "[Of these changes, decreased expression of S100A16 and MGMT can be best reconciled with the current views on the role of their protein products in glioma malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP240801.RA52_c26DqfGGXrRaML8xBAr_UzW-FVElm15xsuxWNLf8130_provenance.